2235 Stock Overview
MicroTech Medical (Hangzhou) Co., Ltd. engages in the research and development, manufacture, and commercialization of diabetes management medical devices and consumables in the People’s Republic of China and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 5/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for 2235 from our risk checks.
MicroTech Medical (Hangzhou) Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | HK$3.99 |
| 52 Week High | HK$7.12 |
| 52 Week Low | HK$3.40 |
| Beta | 0.74 |
| 1 Month Change | -3.39% |
| 3 Month Change | -6.56% |
| 1 Year Change | -43.64% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -86.92% |
Recent News & Updates
Recent updates
MicroTech Medical (Hangzhou) (HKG:2235) Is In A Good Position To Deliver On Growth Plans
Sep 22
News Flash: One MicroTech Medical (Hangzhou) Co., Ltd. (HKG:2235) Analyst Has Been Trimming Their Revenue Forecasts
Jan 20MicroTech Medical (Hangzhou) (HKG:2235) Is In A Good Position To Deliver On Growth Plans
Jan 18Shareholder Returns
| 2235 | HK Medical Equipment | HK Market | |
|---|---|---|---|
| 7D | 2.0% | -2.3% | -2.0% |
| 1Y | -43.6% | -52.7% | -14.3% |
Return vs Industry: 2235 exceeded the Hong Kong Medical Equipment industry which returned -54% over the past year.
Return vs Market: 2235 underperformed the Hong Kong Market which returned -15% over the past year.
Price Volatility
| 2235 volatility | |
|---|---|
| 2235 Average Weekly Movement | 5.9% |
| Medical Equipment Industry Average Movement | 7.4% |
| Market Average Movement | 7.5% |
| 10% most volatile stocks in HK Market | 14.9% |
| 10% least volatile stocks in HK Market | 3.8% |
Stable Share Price: 2235's share price has been volatile over the past 3 months.
Volatility Over Time: 2235's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2011 | 760 | Pan Zheng | www.microtechmd.com |
MicroTech Medical (Hangzhou) Co., Ltd. engages in the research and development, manufacture, and commercialization of diabetes management medical devices and consumables in the People’s Republic of China and internationally. The company’s products include Equil Patch insulin pump systems, AiDEX continuous glucose monitoring systems, POCT analyzer systems, blood glucose monitoring systems, and closed-loop artificial pancreas. It is also involved in engineering and technology research experimentation and development activities.
MicroTech Medical (Hangzhou) Co., Ltd. Fundamentals Summary
| 2235 fundamental statistics | |
|---|---|
| Market cap | HK$1.68b |
| Earnings (TTM) | -HK$135.27m |
| Revenue (TTM) | HK$273.99m |
6.1x
P/S Ratio-12.4x
P/E RatioIs 2235 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 2235 income statement (TTM) | |
|---|---|
| Revenue | CN¥253.23m |
| Cost of Revenue | CN¥127.49m |
| Gross Profit | CN¥125.73m |
| Other Expenses | CN¥250.75m |
| Earnings | -CN¥125.02m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.30 |
| Gross Margin | 49.65% |
| Net Profit Margin | -49.37% |
| Debt/Equity Ratio | 0% |
How did 2235 perform over the long term?
See historical performance and comparison